BlackRock Health Sciences Term Trust (NYSE:BMEZ) Sees Significant Decrease in Short Interest

BlackRock Health Sciences Term Trust (NYSE:BMEZ) saw a significant drop in short interest in January. As of January 15th, there was short interest totalling 48,200 shares, a drop of 61.2% from the December 31st total of 124,200 shares. Based on an average trading volume of 365,000 shares, the short-interest ratio is presently 0.1 days.

BlackRock Health Sciences Term Trust Trading Up 0.4 %

Shares of NYSE:BMEZ traded up $0.06 on Friday, hitting $16.66. 115,664 shares of the company were exchanged, compared to its average volume of 526,112. BlackRock Health Sciences Term Trust has a 1-year low of $14.27 and a 1-year high of $16.75. The stock’s 50 day moving average price is $15.40 and its 200 day moving average price is $15.64.

BlackRock Health Sciences Term Trust Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Friday, January 31st. Investors of record on Wednesday, January 15th will be issued a dividend of $0.1782 per share. The ex-dividend date is Wednesday, January 15th. This represents a $2.14 annualized dividend and a dividend yield of 12.83%.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in BMEZ. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in BlackRock Health Sciences Term Trust in the fourth quarter valued at $471,000. Brown Lisle Cummings Inc. increased its holdings in BlackRock Health Sciences Term Trust by 17.0% in the fourth quarter. Brown Lisle Cummings Inc. now owns 42,711 shares of the company’s stock valued at $615,000 after buying an additional 6,198 shares in the last quarter. Absolute Investment Advisers LLC purchased a new position in BlackRock Health Sciences Term Trust in the fourth quarter valued at $3,941,000. Kingswood Wealth Advisors LLC purchased a new position in BlackRock Health Sciences Term Trust in the fourth quarter valued at $420,000. Finally, K2 Principal Fund L.P. purchased a new position in BlackRock Health Sciences Term Trust in the third quarter valued at $158,000.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.